Welcome to the Regulatory Science Network Netherlands

Regulatory Science Network Netherlands (RSNN) is a network of experts from industry, academia, government bodies, and the broader regulatory science field. Our mission is to advance an efficient and effective regulatory system that supports medicines development, marketing authorization, access, and appropriate use of medicines. RSNN shares and disseminates knowledge among all stakeholders and sets the agenda for further research.

We would love to hear from you!

Submit your ideas, questions or topics for Regulatory Science in the Netherlands and we will be in touch.

Submit your ideas
Interview
08 November 2020

RSNN interview series: Marjon Pasmooij

The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. It also provides an...

Read more
01 June 2021

Thesis defense PhD candidate Renske ten Ham (UU): "Development, market authorization and market access of gene and cell-based therapies"

On 4 June 2021 at 2:15pm PhD candidate Renske ten Ham from Utrecht University will defend her thesis titled: "Development, market authorization and market...

Read more
20 May 2021

MEB publishes Science Policy 2020-2024

Last week the Medicines Evaluation Board (MEB) published its Science Policy 2020-2024 titled 'regulating with the knowledge of tomorrow' The policy document...

Read more
Report
19 February 2021

RSNN Expert Meeting Report - Regulatory challenges for non-biological complex drugs (NBCDs)

On 8 December 2020, RSNN organized an Expert Meeting titled: Regulatory challenges for non-biological complex drugs (NBCDs)

Read more